In vitro assessment of oral delivery for hexapeptide endothelin antagonists
- 16 February 1996
- journal article
- Published by Elsevier in Life Sciences
- Vol. 58 (12) , 971-982
- https://doi.org/10.1016/0024-3205(96)00045-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comparison of Intestinal Permeabilities Determined in Multiple in Vitro and inSitu Models: Relationship to Absorption in HumansPharmaceutical Research, 1995
- Design of C-terminal peptide antagonists of endothelin: structure-activity relationships of ET-[16–21, D-His16]Bioorganic & Medicinal Chemistry Letters, 1993
- In Vitro and In Vivo Studies with a Series of Hexapeptide Endothelin AntagonistsJournal of Cardiovascular Pharmacology, 1993
- Design of a functional hexapeptide antagonist of endothelinJournal of Medicinal Chemistry, 1992
- Endothelin: a new challengeJournal of Medicinal Chemistry, 1992
- Principles and practice of electrospray ionization—mass spectrometry for large polypeptides and proteinsMass Spectrometry Reviews, 1991
- Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cellsBiochemical and Biophysical Research Communications, 1991
- Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial PermeabilityGastroenterology, 1989